FDA Inspection 831892 — Delaware Institute for Reproductive Medicine, P.A
The FDA completed an inspection of Delaware Institute for Reproductive Medicine, P.A on May 16, 2013 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 16, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Newark, DE (United States)